Antenatal corticosteroids for impending late preterm (34-36+6 weeks) deliveries-A systematic review and meta-analysis of RCTs.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
10
11
2020
accepted:
04
03
2021
entrez:
22
3
2021
pubmed:
23
3
2021
medline:
15
10
2021
Statut:
epublish
Résumé
Administration of antenatal corticosteroids (ANC) for impending preterm delivery beyond 34 weeks of gestation continues to be a controversial issue despite various guidelines for obstetricians and gynaecologists. To compare outcomes following exposure to ANC for infants born between 34-36+6 weeks' gestation. A systematic review of randomised controlled trials (RCT) reporting neonatal outcomes after ANC exposure between 34-36+6 weeks' gestation using Cochrane methodology. Databases including PubMed, Embase, Emcare, Cochrane Central library and Google Scholar were searched in May 2020. Primary outcomes: (1) Need for respiratory support (Mechanical ventilation, CPAP, high flow) or oxygen (2) Hypoglycemia. Secondary outcomes included respiratory distress syndrome (RDS), transient tachypnoea of newborn (TTN), need for neonatal resuscitation at birth [only in the delivery room immediately after birth (not in neonatal intensive care unit (NICU)], admission to NICU, mortality and developmental follow up. Level of evidence (LOE) was summarised by GRADE guidelines. Seven RCTs (N = 4144) with low to high risk of bias were included. Only one RCT was from high income countries, Meta-analysis (random-effects model) showed (1) reduced need for respiratory support [5 RCTs (N = 3844); RR = 0.68 (0.47-0.98), p = 0.04; I2 = 55%; LOE: Moderate] and (2) higher risk of neonatal hypoglycaemia [4 RCTs (N = 3604); RR = 1.61(1.38-1.87), p<0.00001; I2 = 0%; LOE: High] after ANC exposure. Neonates exposed to ANC had reduced need for resuscitation at birth. The incidence of RDS, TTN and surfactant therapy did not differ significantly. None of the included studies reported long-term developmental follow up. Moderate quality evidence indicates that ANC exposure reduced need for respiratory support, and increased the risk of hypoglycaemia in late preterm neonates. Large definitive trials with adequate follow up for neurodevelopmental outcomes are required to assess benefits and risks of ANC in this population.
Sections du résumé
BACKGROUND
Administration of antenatal corticosteroids (ANC) for impending preterm delivery beyond 34 weeks of gestation continues to be a controversial issue despite various guidelines for obstetricians and gynaecologists.
OBJECTIVE
To compare outcomes following exposure to ANC for infants born between 34-36+6 weeks' gestation.
METHODS
A systematic review of randomised controlled trials (RCT) reporting neonatal outcomes after ANC exposure between 34-36+6 weeks' gestation using Cochrane methodology. Databases including PubMed, Embase, Emcare, Cochrane Central library and Google Scholar were searched in May 2020. Primary outcomes: (1) Need for respiratory support (Mechanical ventilation, CPAP, high flow) or oxygen (2) Hypoglycemia. Secondary outcomes included respiratory distress syndrome (RDS), transient tachypnoea of newborn (TTN), need for neonatal resuscitation at birth [only in the delivery room immediately after birth (not in neonatal intensive care unit (NICU)], admission to NICU, mortality and developmental follow up. Level of evidence (LOE) was summarised by GRADE guidelines.
MAIN RESULTS
Seven RCTs (N = 4144) with low to high risk of bias were included. Only one RCT was from high income countries, Meta-analysis (random-effects model) showed (1) reduced need for respiratory support [5 RCTs (N = 3844); RR = 0.68 (0.47-0.98), p = 0.04; I2 = 55%; LOE: Moderate] and (2) higher risk of neonatal hypoglycaemia [4 RCTs (N = 3604); RR = 1.61(1.38-1.87), p<0.00001; I2 = 0%; LOE: High] after ANC exposure. Neonates exposed to ANC had reduced need for resuscitation at birth. The incidence of RDS, TTN and surfactant therapy did not differ significantly. None of the included studies reported long-term developmental follow up.
CONCLUSIONS
Moderate quality evidence indicates that ANC exposure reduced need for respiratory support, and increased the risk of hypoglycaemia in late preterm neonates. Large definitive trials with adequate follow up for neurodevelopmental outcomes are required to assess benefits and risks of ANC in this population.
Identifiants
pubmed: 33750966
doi: 10.1371/journal.pone.0248774
pii: PONE-D-20-35297
pmc: PMC7984612
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0248774Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Matern Fetal Neonatal Med. 2020 Aug;33(15):2533-2540
pubmed: 30612482
Pediatrics. 2017 Mar;139(3):
pubmed: 28148728
BMJ. 2016 Oct 12;355:i5044
pubmed: 27733360
Ann Intern Med. 2009 Aug 18;151(4):W65-94
pubmed: 19622512
Cochrane Database Syst Rev. 2017 Mar 21;3:CD004454
pubmed: 28321847
Obstet Gynecol. 2009 Jan;113(1):142-151
pubmed: 19104370
Arch Dis Child Fetal Neonatal Ed. 2015 Nov;100(6):F479-85
pubmed: 25834169
JAMA. 2020 May 19;323(19):1924-1933
pubmed: 32427304
Pediatr Res. 2007 Jul;62(1):32-6
pubmed: 17515831
J Trop Pediatr. 2018 Dec 1;64(6):531-538
pubmed: 29365196
Pediatrics. 2008 Feb;121(2):e223-32
pubmed: 18245397
Arch Dis Child Fetal Neonatal Ed. 2013 May;98(3):F195-200
pubmed: 23424017
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880
BMJ. 2011 Apr 12;342:d1696
pubmed: 21487057
Reprod Fertil Dev. 1994;6(2):141-50
pubmed: 7991781
Pediatrics. 2009 Feb;123(2):653-9
pubmed: 19171634
Am J Obstet Gynecol. 1995 Jul;173(1):254-62
pubmed: 7631700
Pediatrics. 2015 Oct;136(4):819-22
pubmed: 26416932
Pediatrics. 1998 Jan;101(1 Pt 1):77-81
pubmed: 9417155
J Dev Orig Health Dis. 2015 Apr;6(2):127-42
pubmed: 25466556
Am J Obstet Gynecol. 2018 Jul;219(1):62-74
pubmed: 29630886
Gynecol Obstet Invest. 2010;70(2):95-9
pubmed: 20234136
J Perinatol. 2017 Jun;37(6):624-625
pubmed: 28333158
Obstet Gynecol. 1999 Aug;94(2):213-8
pubmed: 10432130
Semin Fetal Neonatal Med. 2019 Feb;24(1):3-10
pubmed: 30309813
J Clin Epidemiol. 2013 Feb;66(2):158-72
pubmed: 22609141
Semin Fetal Neonatal Med. 2019 Feb;24(1):37-42
pubmed: 30322825
J Pediatr. 1986 Nov;109(5):865-8
pubmed: 3772665
Am J Obstet Gynecol. 2016 Oct;215(4):423-30
pubmed: 27342043
Eur J Epidemiol. 2018 Oct;33(10):1011-1020
pubmed: 30030683
Obstet Gynecol. 2017 Aug;130(2):e102-e109
pubmed: 28742678
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Neonatology. 2019;115(2):116-126
pubmed: 30408811
Brain Res Rev. 2008 Mar;57(2):586-95
pubmed: 17716742
N Engl J Med. 2016 Apr 7;374(14):1311-20
pubmed: 26842679
J Obstet Gynaecol Can. 2018 Sep;40(9):1219-1239
pubmed: 30268316